Quest Diagnostics (DGX) Payables (2009 - 2026)

Quest Diagnostics has disclosed Payables across 18 years of filings, most recently posting $1.6 billion for Q2 2026.

• In Q2 2026, Payables rose 18.46% year-over-year to $1.6 billion; the TTM figure through Jun 2026 stood at $1.6 billion (up 18.46% YoY), while the FY2025 annual figure was $1.6 billion, up 14.78% from the prior year.
• Payables came in at $1.6 billion for Q2 2026 at Quest Diagnostics, up from $1.5 billion in the prior quarter.
• In the past five years, Payables ranged from a high of $1.6 billion in Q4 2025 to a low of $1.2 billion in Q3 2023.
• Average Payables over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2023.
• Year-over-year, Payables retreated 22.41% in 2023 and climbed 18.46% in 2026.
• Over 5 years, Payables stood at $1.4 billion in 2022, then retreated by 2.65% to $1.4 billion in 2023, then advanced by 2.58% to $1.4 billion in 2024, then climbed by 14.78% to $1.6 billion in 2025, then decreased by 0.12% to $1.6 billion in 2026.
• Per Business Quant data, the three most recent Payables figures were $1.6 billion in Q2 2026, $1.5 billion in Q1 2026, and $1.6 billion in Q4 2025.